Published in Blood on May 12, 2005
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest (2008) 3.11
Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner. J Leukoc Biol (2009) 1.64
c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol Ther (2008) 1.15
Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases. Prostate (2010) 1.15
Early growth response genes regulate B cell development, proliferation, and immune response. J Immunol (2008) 1.14
JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol (2014) 1.11
Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells. Cancer Cell Int (2007) 1.08
Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms. Mol Biol Cell (2006) 1.07
B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. J Clin Invest (2007) 1.05
Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study. PLoS One (2014) 0.96
c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells. J Transl Med (2011) 0.96
YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway. Br J Pharmacol (2008) 0.95
Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth. Mol Cancer (2009) 0.92
A novel herbal medicine, KIOM-C, induces autophagic and apoptotic cell death mediated by activation of JNK and reactive oxygen species in HT1080 human fibrosarcoma cells. PLoS One (2014) 0.91
Searching in mother nature for anti-cancer activity: anti-proliferative and pro-apoptotic effect elicited by green barley on leukemia/lymphoma cells. PLoS One (2013) 0.90
Regulation of Lhb and Egr1 gene expression by GNRH pulses in rat pituitaries is both c-Jun N-terminal kinase (JNK)- and extracellular signal-regulated kinase (ERK)-dependent. Biol Reprod (2009) 0.90
Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability. J Virol (2013) 0.87
Nuclear receptor LRH-1/NR5A2 is required and targetable for liver endoplasmic reticulum stress resolution. Elife (2014) 0.86
Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth. PLoS One (2012) 0.84
JNK regulates serotonin-mediated proliferation and migration of pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2010) 0.83
Lactobacillus helveticus SBT2171 inhibits lymphocyte proliferation by regulation of the JNK signaling pathway. PLoS One (2014) 0.83
CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes. Mol Immunol (2009) 0.82
Disassembly of the JIP1/JNK molecular scaffold by caspase-3-mediated cleavage of JIP1 during apoptosis. Exp Cell Res (2011) 0.81
JNK signaling maintains the mesenchymal properties of multi-drug resistant human epidermoid carcinoma KB cells through snail and twist1. BMC Cancer (2013) 0.81
Targeting early B-cell receptor signaling induces apoptosis in leukemic mantle cell lymphoma. Exp Hematol Oncol (2013) 0.80
Role of B cell receptor signaling in IL-10 production by normal and malignant B-1 cells. Ann N Y Acad Sci (2015) 0.79
ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex. Mol Cancer (2014) 0.79
Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation. Mol Cell Biol (2013) 0.79
Anti-cancer activity of withaferin A in B-cell lymphoma. Cancer Biol Ther (2015) 0.79
Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation. Cell Mol Immunol (2013) 0.78
CD137 is induced by the CD40 signal on chronic lymphocytic leukemia B cells and transduces the survival signal via NF-κB activation. PLoS One (2013) 0.76
Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms. Clin Exp Med (2016) 0.76
Low Dose Cadmium Inhibits Proliferation of Human Renal Mesangial Cells via Activation of the JNK Pathway. Int J Environ Res Public Health (2016) 0.75
Expressions of SH3BP5, LMO3, and SNAP25 in diffuse large B-cell lymphoma cells and their association with clinical features. Cancer Med (2016) 0.75
Gamma-secretase Inhibitor Prevents Proliferation and Migration of Ductus Arteriosus Smooth Muscle Cells through the Notch3-HES1/2/5 Pathway. Int J Biol Sci (2016) 0.75
A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma. PLoS One (2017) 0.75
Smad4 inhibits cell migration via suppression of JNK activity in human pancreatic carcinoma PANC-1 cells. Oncol Lett (2016) 0.75
ArtinM Mediates Murine T Cell Activation and Induces Cell Death in Jurkat Human Leukemic T Cells. Int J Mol Sci (2017) 0.75
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Signal transduction by the JNK group of MAP kinases. Cell (2000) 18.24
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A (2001) 11.06
AP-1 as a regulator of cell life and death. Nat Cell Biol (2002) 10.10
The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron (1999) 4.51
BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol (1999) 4.00
A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell (2003) 3.90
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J Exp Med (1988) 3.80
Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity (1998) 3.70
The JNK signal transduction pathway. Curr Opin Genet Dev (2002) 3.35
Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov (2003) 3.11
TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity (1997) 2.96
MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev (2001) 2.48
Cell cycle deregulation in B-cell lymphomas. Blood (2002) 2.41
JunD mediates survival signaling by the JNK signal transduction pathway. Mol Cell (2003) 2.39
Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J (1994) 2.33
Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol (1999) 2.25
Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J (2002) 2.00
Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma. Proc Natl Acad Sci U S A (1984) 1.76
JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell (2004) 1.73
JNK and p38 stresskinases--degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol (2000) 1.62
Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J Exp Med (2004) 1.58
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood (1993) 1.52
Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem (1998) 1.51
Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat Genet (2002) 1.48
Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol Cell (2003) 1.47
An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J Biol Chem (2003) 1.47
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci U S A (2003) 1.42
Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol Cell (2004) 1.38
Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene (2004) 1.36
The p65/RelA subunit of NF-kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor. Mol Cell Biol (2002) 1.36
Transcriptional regulation of the Icam-1 gene in antigen receptor- and phorbol ester-stimulated B lymphocytes: role for transcription factor EGR1. J Exp Med (1996) 1.36
Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J Biol Chem (1995) 1.33
CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth. J Immunol (1995) 1.29
Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia. Oncogene (2004) 1.26
The role of early growth response gene 1 (egr-1) in regulation of the immune response. J Leukoc Biol (1996) 1.25
Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage. Am J Pathol (2001) 1.21
Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol (1999) 1.19
Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J Immunol (1995) 1.19
Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol Cell Biol (1996) 1.15
Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases. Int Immunol (2003) 1.14
Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma. Leukemia (2004) 1.13
Analysis of functional elements in the human Egr-1 gene promoter. Rheumatol Int (1999) 1.11
Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1. Cancer Res (2000) 1.10
Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J Exp Med (1994) 1.10
The platelet-derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway. J Biol Chem (2003) 1.05
Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood (1998) 1.04
Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10. Blood (1995) 1.03
Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell lines. Oncogene (2003) 1.01
Cell cycle regulation of the c-Myc transcriptional activation domain. Mol Cell Biol (1993) 1.01
A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death. Eur J Immunol (1999) 1.00
Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines. Blood (2004) 0.98
Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma. Blood (2003) 0.96
Micro-environmental factors in the survival of human B-lymphoma cells. Cell Death Differ (2000) 0.91
Differential roles for extracellularly regulated kinase-mitogen-activated protein kinase in B cell antigen receptor-induced apoptosis and CD40-mediated rescue of WEHI-231 immature B cells. J Immunol (2002) 0.89
Induction of G(2)/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes. Biochem Pharmacol (2002) 0.88
Down-modulation of c-myc expression induces apoptosis of B lymphocyte models of tolerance via clonal deletion. J Immunol (1997) 0.87
c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells. Prostate (2003) 0.87
Role of Egr-1 gene expression in B cell receptor-induced apoptosis in an immature B cell lymphoma. J Biol Chem (1997) 0.86
The EGR1 protein contains a discrete transcriptional regulatory domain whose deletion results in a truncated protein that blocks EGR1-induced transcription. DNA Cell Biol (1995) 0.85
CpG oligodeoxynucleotides rescue BKS-2 immature B cell lymphoma from anti-IgM-mediated growth inhibition by up-regulation of egr-1. Int Immunol (1999) 0.85
Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation. J Immunol (2001) 0.84
An investigation of the effects of the MEK inhibitor U0126 on apoptosis in acute leukemia. Hematol J (2003) 0.83
CpG oligodeoxynucleotides overcome the unresponsiveness of neonatal B cells to stimulation with the thymus-independent stimuli anti-IgM and TNP-Ficoll. Eur J Immunol (1999) 0.82
An investigation of the MEK/ERK inhibitor U0126 in acute myeloid leukemia. Ann N Y Acad Sci (2003) 0.82
CpG oligodeoxynucleotides stimulate cord blood mononuclear cells to produce immunoglobulins. Clin Immunol (2005) 0.82
Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis. Oncogene (1999) 0.80
Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes. J Immunol (1998) 0.80
Isolation and immunological characterization of a group of new B lymphomas from CBA mice. Clin Immunol Immunopathol (1989) 0.79
Involvement of cell cycle progression in survival signaling through CD40 in the B-lymphocyte line WEHI-231. Cell Death Differ (2004) 0.79
Stress kinase MKK7: savior of cell cycle arrest and cellular senescence. Cell Cycle (2004) 0.78
Cutting edge: constitutive B cell receptor signaling is critical for basal growth of B lymphoma. J Immunol (2006) 1.77
Structural basis for molecular recognition of folic acid by folate receptors. Nature (2013) 1.62
Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol (2006) 1.59
Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response. Sci Signal (2011) 1.58
Alloantibody to a Bw4 epitope in a Bw4+B*27: 05 patient. Transplantation (2014) 1.39
The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function. J Leukoc Biol (2005) 1.36
Cancer resistance in transgenic mice expressing the SAC module of Par-4. Cancer Res (2007) 1.25
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology (2008) 1.25
LRP5 and LRP6 in development and disease. Trends Endocrinol Metab (2013) 1.21
Early growth response genes regulate B cell development, proliferation, and immune response. J Immunol (2008) 1.14
Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth. J Immunol (2007) 1.14
Commentary: Health care reform and primary care: training physicians for tomorrow's challenges. Acad Med (2011) 0.99
CD5 plays an inhibitory role in the suppressive function of murine CD4(+) CD25(+) T(reg) cells. Immunol Lett (2008) 0.99
Structure of a PLS-class pentatricopeptide repeat protein provides insights into mechanism of RNA recognition. J Biol Chem (2013) 0.99
Systemic Par-4 inhibits non-autochthonous tumor growth. Cancer Biol Ther (2011) 0.99
Kinetic and structural insight into the mechanism of BphD, a C-C bond hydrolase from the biphenyl degradation pathway. Biochemistry (2006) 0.98
The ORF3 protein of porcine circovirus type 2 interacts with porcine ubiquitin E3 ligase Pirh2 and facilitates p53 expression in viral infection. J Virol (2007) 0.97
Involvement of DNA mismatch repair in folate deficiency-induced apoptosis small star, filled. J Nutr Biochem (2002) 0.94
Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection. PLoS One (2010) 0.94
Characterization of a C-C bond hydrolase from Sphingomonas wittichii RW1 with novel specificities towards polychlorinated biphenyl metabolites. J Bacteriol (2007) 0.94
The role of MAPKs in B cell receptor-induced down-regulation of Egr-1 in immature B lymphoma cells. J Biol Chem (2006) 0.93
Multiple regulatory mechanisms control B-1 B cell activation. Front Immunol (2012) 0.92
Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth. Mol Cancer (2009) 0.92
Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations. Mol Immunol (2002) 0.90
Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. Am J Med Genet B Neuropsychiatr Genet (2003) 0.90
Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages. J Leukoc Biol (2007) 0.88
CD4+ T cells mediate murine syngeneic graft-versus-host disease-associated colitis. J Immunol (2004) 0.87
Doxorubicin-induced thymus senescence. J Proteome Res (2010) 0.87
Role of phosphoinositide 3-kinase-Akt signaling pathway in the age-related cytokine dysregulation in splenic macrophages stimulated via TLR-2 or TLR-4 receptors. Mech Ageing Dev (2011) 0.87
Lessons from industry: one school's transformation toward "lean" curricular governance. Acad Med (2007) 0.86
Multifactorial patterns of gene expression in colonic epithelial cells predict disease phenotypes in experimental colitis. Inflamm Bowel Dis (2012) 0.85
CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function. J Clin Immunol (2008) 0.84
Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth. PLoS One (2012) 0.84
Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion. Proc Natl Acad Sci U S A (2011) 0.83
Preferential loss of mismatch repair function in refractory and relapsed acute myeloid leukemia: potential contribution to AML progression. Cell Res (2008) 0.83
CpG oligodeoxynucleotides stimulate cord blood mononuclear cells to produce immunoglobulins. Clin Immunol (2005) 0.82
CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes. Mol Immunol (2009) 0.82
IFN-gamma-mediated inhibition of antigen receptor-induced B cell proliferation and CREB-1 binding activity requires STAT-1 transcription factor. Eur J Immunol (2003) 0.81
The role of B cells and accessory cells in the neonatal response to TI-2 antigens. Immunol Res (2005) 0.80
A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma. Blood (2011) 0.80
Development of a T(H)17 immune response during the induction of murine syngeneic graft-versus-host disease. Cytokine (2010) 0.80
Murine syngeneic graft-versus-host disease is responsive to broad-spectrum antibiotic therapy. J Immunol (2011) 0.80
Adoptive transfer of murine syngeneic graft-vs.-host disease by CD4+ T cells. J Leukoc Biol (2007) 0.80
Enhanced replication of porcine circovirus type 2 (PCV2) in a homogeneous subpopulation of PK15 cell line. Virology (2007) 0.79
Bone marrow dendritic cell-mediated regulation of TLR and B cell receptor signaling in B cells. J Immunol (2012) 0.79
Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease. Am J Physiol Gastrointest Liver Physiol (2010) 0.78
Erratum: structural basis of AMPK regulation by adenine nucleotides and glycogen. Cell Res (2015) 0.77
Characterization and epitope mapping of monoclonal antibodies recognizing N-terminus of Rep of porcine circovirus type 2. J Virol Methods (2010) 0.76
A gut feeling about murine syngeneic GVHD. Chimerism (2011) 0.76
Accumulation of CD4+ T cells in the colon of CsA-treated mice following myeloablative conditioning and bone marrow transplantation. Am J Physiol Gastrointest Liver Physiol (2011) 0.76
Induction of murine syngeneic graft-versus-host disease by cells of recipient origin. Transplantation (2007) 0.76
Anti-IL-23p19 therapy inhibits the adoptive transfer of syngeneic graft-versus-host disease. Cytokine (2013) 0.75
Impact of 2,3,7,8-tetrachlorodibenzo-p-dioxin on cutaneous wound healing. Exp Toxicol Pathol (2011) 0.75
Regulation of the mucosal phenotype in dendritic cells by PPARγ: role of tissue microenvironment. J Leukoc Biol (2013) 0.75
Broadly reactive anti-HLA antibodies after a single unit transfusion with nonleukoreduced red blood cells. Am Surg (2014) 0.75
Positive and negative roles of CD72 in B cell function. Immunol Res (2002) 0.75
The Kentucky medical curriculum: continuing innovations in educating physicians. J Ky Med Assoc (2006) 0.75
University of Kentucky (UK) College of Medicine. Acad Med (2010) 0.75